Good news for Matinas BioPharma’s treatment for Chronic Refractory Mucocutaneous Candidiasis
Matinas BioPharma Holdings said Monday that the National Institutes of Health (NIH) has revealed positive data from a third patient…
Pharmaceuticals, Biotechnology and Life Sciences
Matinas BioPharma Holdings said Monday that the National Institutes of Health (NIH) has revealed positive data from a third patient…
Faller, a German-based player in packaging in the pharma industry is presenting three prototypes in line with the theme of…
Celgene Corporation and Impact Biomedicines have agreed for Celgene to acquire Impact Biomedicines, which is developing fedratinib for myelofibrosis and…
Novo Nordisk on Monday confirmed proposing on December 22, 2017 to acquire Ablynx for €28.00 per share in cash and…
Targovax ASA, a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announced on Monday that Michael…
Pharmapack Europe 2018 will have a programme for Europe’s dedicated pharmaceutical packaging and drug delivery conference and exhibition taking place…
Belgian-based biopharmaceutical company TiGenix NV on Friday confirmed that Takeda Pharmaceutical Company has announced its intention buy TiGenix.
Merck’s anti PD-1 therapy Keytruda has been approved by the Japanese Ministry of Health, Labor and Welfare (MHLW) to treat…
Novartis could soon offer SAA patients new treatment, as it on Thursday announced getting the Breakthrough Therapy for its Promacta…
Mereo BioPharma Group has finished £10 million tranche of the credit loan set up in August 2017 with Silicon Valley…